BLOG

How Do Stem Cells Find Damage? The Homing Effect Explained

Published 2026.10.16 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Regenerative medicine, particularly treatments using stem cells, is a field of growing interest. One of the common questions we hear is, “If stem cells are administered through an IV drip, how do they know where to go in the body to be effective?” The answer lies in a remarkable natural process known as the ‘homing effect.’ This article explains the mechanism that allows infused stem cells to navigate toward areas of injury or inflammation.

The core concept is that mesenchymal stem cells (MSCs), a type of stem cell often used in these therapies, possess an innate ability to detect and migrate to damaged tissues. When administered intravenously, they don’t just circulate randomly. Instead, they respond to specific chemical signals released by injured cells. This targeted migration is what makes systemic (whole-body) IV therapy a viable approach for addressing chronic inflammation and age-related decline. However, it’s important to understand that this process is complex, and its efficiency can vary among individuals. A physician’s assessment is crucial to determine if this approach is suitable for your specific condition.

Understanding the Stem Cell ‘Homing Effect’

Imagine your body has an internal GPS. When a tissue is damaged or inflamed, it sends out a distress signal, like an ‘SOS’ call. The ‘homing effect’ is the process by which circulating stem cells detect these signals and travel to the source of the problem. This is a natural repair mechanism that our bodies use constantly, but its efficiency can decline with age as the number of available stem cells decreases. Adipose-derived stem cell therapy aims to support this process by introducing a concentrated number of your own cultured stem cells back into your system.

The mechanism can be broken down into a few key steps:

Inflammation Signals: Damaged or inflamed tissues release specific proteins called cytokines and chemokines. These molecules act as chemical beacons, creating a gradient in the bloodstream that signals where the damage is located.
Adhesion and Rolling: As stem cells travel through the blood vessels, they have receptors on their surface that recognize these signals. When they pass near an inflamed area, they begin to slow down, ‘roll’ along the vessel wall, and adhere to it.
Transmigration: Once attached to the blood vessel wall, the stem cells squeeze through the gaps between the endothelial cells—a process called transmigration or diapedesis—and enter the surrounding tissue.
Migration to the Target: After exiting the bloodstream, the stem cells follow the chemical trail directly to the site of injury, where they can begin to exert their therapeutic effects, such as calming inflammation and supporting tissue repair.

Why Use Adipose-Derived Stem Cells via IV Infusion?

Mesenchymal stem cells (MSCs) can be sourced from various tissues, including bone marrow and fat (adipose) tissue. At Grand Green Osaka Umekita Clinic, we use adipose-derived MSCs. This is because fat tissue is an abundant source of MSCs, and they can be collected with a minimally invasive procedure under local anesthesia.

Administering these cells via an IV infusion allows for a systemic, whole-body approach. While local injections are suitable for specific, isolated issues like a single joint, IV therapy may be considered for more widespread conditions, such as chronic inflammation or systemic effects of aging. The homing effect enables the infused cells to potentially reach multiple sites of low-grade inflammation throughout the body that may not be easily identifiable or accessible for direct injection. This approach is based on supporting the body’s overall regenerative capacity rather than targeting a single symptom.

Important Considerations for Regenerative Medicine in Japan

While the science behind the homing effect is compelling, it’s essential to approach regenerative medicine with a clear understanding of what to expect. Any potential treatment plan must be based on a thorough medical evaluation by a qualified physician.

Here are some key points to consider:

Physician Consultation is Essential: Your eligibility for stem cell therapy depends on your overall health, medical history, and specific concerns. A doctor’s diagnosis is required to determine if this treatment is an appropriate option for you.
Not Covered by Public Insurance: Adipose-derived stem cell therapy is considered an elective treatment and is not covered by Japanese public health insurance. This is known as free practice (jiyu shinryo).
Regulatory Framework: In Japan, regenerative therapies are provided under the Act on the Safety of Regenerative Medicine. This requires clinics to submit a treatment plan to the Ministry of Health, Labour and Welfare, ensuring specific standards for safety and cell processing are met.
No Guarantees of Efficacy: The homing effect is a reported biological mechanism, but it does not guarantee a specific therapeutic outcome. Individual results can vary, and the treatment is not a cure for diseases.
Potential Risks and Side Effects: As with any medical procedure, there are potential risks and side effects. It is crucial to have a detailed discussion with your doctor about the potential benefits and risks before proceeding.

Explore Adipose-Derived Stem Cell Therapy in Osaka

The homing effect is a foundational principle that makes systemic stem cell therapy a logical approach for supporting the body’s natural repair functions. By understanding how your own cells can be harnessed to target areas of need, you can make a more informed decision about your long-term health.

At Grand Green Osaka Umekita Clinic, we provide adipose-derived stem cell therapy in compliance with Japan’s regulatory standards. If you are interested in learning more about how this treatment leverages the homing effect for a whole-body approach, we invite you to consult with our physicians. For detailed information on the treatment process, costs, and potential risks, please see our dedicated page on Adipose-Derived Stem Cell Therapy.

Our clinic is conveniently located in Osaka (Umeda) and provides information for international visitors. Feel free to contact us to learn more about your options.

Learn more about Adipose-Derived Stem Cell Therapy here.

Summary: The Guided Journey of Stem Cells

The stem cell homing effect is a sophisticated, natural process that allows intravenously administered stem cells to find their way to sites of damage and inflammation. This mechanism is the basis for using IV infusion as a systemic approach in regenerative medicine. By supporting the body’s innate repair systems, this therapy offers a potential option for those concerned with chronic inflammation and the effects of aging. As this is an evolving field, making an informed decision in consultation with a medical professional is the most important first step.

How Stem Cells Find Damage: The Homing Effect

1SOS Signals from DamageInjured tissues release chemical signals
2Stem Cells Detect SignalsStem cells in the blood adhere to vessel walls
3Passing Through Vessel WallsThey pass through the vessel wall into the tissue
4Migration to the TargetThey migrate to the injury site to support repair

This is a conceptual diagram to summarize the content of the article

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›